CATX
Perspective Therapeutics, Inc.
Key Financials
Operating Income
$-113564000
↓ 25.0%
Net Income
$-103121000
↓ 30.1%
Gross Profit
$1.4M
↑ Infinity%
Total Liabilities
$59.9M
↑ 18.9%
Total Assets
$267.0M
↓ 21.7%
EPS (Diluted)
$-1.40
↓ 13.8%
Long-term Debt
$1.6M
↓ 3.1%
Shareholders' Equity
$207.0M
↓ 28.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 10/1/2026 | View on SEC |
| SCHEDULE 13D/A | 9/23/2026 | View on SEC |
| 8-K | 9/14/2026 | View on SEC |
| 8-K | 9/8/2026 | View on SEC |
| 4 | 9/8/2026 | View on SEC |
| 4 | 9/4/2026 | View on SEC |
| 4 | 9/4/2026 | View on SEC |
| SCHEDULE 13D/A | 9/4/2026 | View on SEC |
| 4 | 9/3/2026 | View on SEC |
| 4 | 9/2/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CATX |
| Company Name | Perspective Therapeutics, Inc. |
| CIK | 728387 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | NYSE |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 206-676-0900 |